APA (7th ed.) Citation

Batty, G., Li, Q., Huxley, R., Zoungas, S., Taylor, B., Neal, B., . . . Chalmers, J. (2013). Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. European psychiatry, 28(1), 49-52. https://doi.org/10.1016/j.eurpsy.2011.07.005

Chicago Style (17th ed.) Citation

Batty, G.-D, et al. "Oral Disease in Relation to Future Risk of Dementia and Cognitive Decline: Prospective Cohort Study Based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) Trial." European Psychiatry 28, no. 1 (2013): 49-52. https://doi.org/10.1016/j.eurpsy.2011.07.005.

MLA (9th ed.) Citation

Batty, G.-D, et al. "Oral Disease in Relation to Future Risk of Dementia and Cognitive Decline: Prospective Cohort Study Based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) Trial." European Psychiatry, vol. 28, no. 1, 2013, pp. 49-52, https://doi.org/10.1016/j.eurpsy.2011.07.005.